Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Abbott Laboratories (NY: ABT)
36.59 USD  -0.24 (-0.65%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Abbott Laboratories
 
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
39 40 Next >
RBCC Identifies Promising New Business Targets at Texas’ Premiere Life Sciences Forum
March 12, 2012
from Business Wire News Releases
Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance
March 08, 2012
The Newest Meter in Abbott's Portfolio of Products Features Automated Logbook, Touch Screen Interface and USB Connectivity for Plug-and-Play Reports Read More
from PR Newswire
Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
March 07, 2012
Incorporates Advanced Technologies Designed for Precise Stent Placement and Optimal Flexibility to Conform to Challenging Lesions Read More
from PR Newswire
Abbott to Present at Barclays Capital 2012 Global Healthcare Conference
March 07, 2012
from PR Newswire
Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
March 06, 2012
from PR Newswire
Abbott to Collaborate on Rapid Molecular Test to Identify Serious Infections in Bones and Joints
March 05, 2012
from PR Newswire
Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence
March 02, 2012
from PR Newswire
Abbott to Build Nutrition Manufacturing Facility in Ohio
March 01, 2012
Plant to Employ 240 to Meet Fast-Growing Demand for Adult Nutrition Products Read More
from PR Newswire
RBCC Initiates Talks With Emerging Drug Therapy Co.
February 29, 2012
from Business Wire News Releases
Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases
February 29, 2012
Selective JAK1 inhibitor in Phase II clinical development for rheumatoid arthritis Read More
from Marketwired News Releases
Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases
February 29, 2012
Selective JAK1 inhibitor in Phase II clinical development for rheumatoid arthritis Read More
from PR Newswire
BioCurex Wholly Owned Subsidiary, OncoPet Diagnostics, Signs Distribution Agreement With Animal Health International
February 28, 2012
from GlobeNewswire News Releases
Abbott Collaborates with Leading U.S. Forensics Center on Human Identification Testing
February 23, 2012
UNT Health Science Center Evaluating Abbott's PLEX-ID System and Mitochondrial DNA Assay Read More
from PR Newswire
Abbott to Present at Cowen and Company 32nd Annual Health Care Conference
February 23, 2012
from PR Newswire
Cancer Stem Cell Research Drives Growth in RBCC’s Target Market
February 22, 2012
from Business Wire News Releases
Abbott Announces 40th Consecutive Annual Increase in Quarterly Dividend
February 17, 2012
from PR Newswire
RBCC Sets Sights on Top Emerging Biotech Innovations
February 17, 2012
from Business Wire News Releases
Pharmaceutical-Bio Industry Closes the Door on 2011 With More Than $12 billion in North American Project Starts, an Industrial Info News Alert
February 15, 2012
from Marketwired News Releases
RBCC Set to Go Global With n3D
February 15, 2012
from Business Wire News Releases
Study Shows Abbott's Tacrolimus Assay Demonstrates Consistent Organ Transplant Drug Monitoring
February 13, 2012
Accurate and Precise Lab-to-Lab Monitoring Is Essential for Long-term Transplant Success Read More
from PR Newswire
A Forward Look, the Year Ahead - Featured Research on Acorda Therapeutics Inc and Abbott Laboratories
February 09, 2012
from Marketwired News Releases
Abbott Creates New Similac SimplySmart™ Baby Bottle with Innovative Features
February 08, 2012
Designed with input from moms, Similac SimplySmart is inspired by 85 years of feeding expertise from the Similac® brand Read More
from PR Newswire
Big VC Biotech Spending on the Rise for 2012
February 08, 2012
from Business Wire News Releases
RBCC Negotiates Funding Terms With n3D
February 06, 2012
from Business Wire News Releases
RBCC: Biotech Industry on Major Upswing in 2012
February 03, 2012
from Business Wire News Releases
Abbott to Present at Leerink Swann 2012 Global Healthcare Conference
February 01, 2012
from PR Newswire
DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases
January 30, 2012
from PR Newswire
RBCC Explores New Cures for Cancer, Brain Injuries & Headaches
January 30, 2012
from Business Wire News Releases
Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in Fourth Quarter and Full-Year 2011
January 25, 2012
-- Fourth Quarter Ongoing EPS of $1.45, Up 11.5 Percent -- Read More
from PR Newswire
RBCC Vets Investment Banks for Capital Raise
January 23, 2012
from Business Wire News Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
39 40 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here